Total parotidectomy--a routine treatment for parotid gland swellings?

J Laryngol Otol

Department of Otolaryngology, University of Florence, Italy.

Published: February 1989

The results of 25 years of quasi-routine total parotidectomy performance are shown. At the Department of Otolaryngology of the University of Florence, 582 patients were treated as follows: on 527 occasions by total parotidectomy with facial nerve preservation; 24 occasions by lateral lobectomy; 27 occasions by total parotidectomy with removal of the whole facial nerve; four times by enucleo-resection of the disease. Benign tumours were 378; primary and metastatic malignant tumours--100; non tumoral lesions--104. The benign tumours follow-up showed three recurrences only (two pleomorphic adenomas--one of them proved to be an adenoid-cystic carcinoma, and one monomorphic adenoma, which also proved to be an adenoid-cystic carcinoma), respectively 6, 6 and 8 years later. The malignant tumours were also treated by total parotidectomy with adequate management both of the facial nerve and the neck lymph nodes. The results thoroughly justify the nerve preservation, when preserved.

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0022215100108394DOI Listing

Publication Analysis

Top Keywords

total parotidectomy
16
facial nerve
12
occasions total
8
nerve preservation
8
benign tumours
8
proved adenoid-cystic
8
adenoid-cystic carcinoma
8
total
5
total parotidectomy--a
4
parotidectomy--a routine
4

Similar Publications

Frey's syndrome surgical treatment may be either prophylactic or therapeutic. The aim of this study is to summarize the state of the art in Frey's syndrome surgical treatment after parotidectomy and review indications, advantages, and disadvantages of different surgical options. The study was conducted following the PRISMA guidelines for scoping reviews; to fulfill the research enquiries, four different electronic databases (PubMed, Scopus, Cochrane, and Web of Science) were searched using the PICO protocol and key words in Frey's syndrome surgical treatment.

View Article and Find Full Text PDF

Introduction: Giant basal cell carcinoma (GBCC) is a rare and aggressive subtype of basal cell carcinoma (BCC), characterized by a diameter of ≥5 cm and a potential for deep tissue invasion. This study aimed to present our experience with the surgical management of GBCC in the maxillofacial region, focusing on resection and immediate reconstruction strategies.

Methods: We conducted a retrospective analysis of 5926 patients with BCC in the maxillofacial region from 2010 to 2020, with a specific emphasis on 32 patients diagnosed with GBCC.

View Article and Find Full Text PDF

Clinical and patient-reported outcomes between full-endoscopic and conventional parotidectomy: a prospective cohort study.

Clin Oral Investig

January 2025

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.

Objectives: This study investigates the clinical and patient-reported outcomes of full-endoscopic parotidectomy compared to the conventional approach.

Methods: Between July 2021 and December 2023, patients who underwent parotidectomy were prospectively enrolled and assigned to either the full-endoscopic parotidectomy group (Group I) or the conventional surgery group (Group II). Clinical outcomes were evaluated, and patient-reported outcomes were assessed using a Visual Analogue Scale and five FACE-Q scales.

View Article and Find Full Text PDF

Purpose: There is no current standard treatment regimen for carcinoma ex pleomorphic adenoma (CXPA) of the lacrimal gland. Neoadjuvant intraarterial cytoreductive chemotherapy (IACC) followed by multimodal therapy has achieved good locoregional control in adenoid cystic carcinoma of the lacrimal gland. We reviewed our experience with neoadjuvant IACC followed by multimodal therapy for CXPA of the lacrimal gland.

View Article and Find Full Text PDF

The Impact of Inflammation on the Etiopathogenesis of Benign Salivary Gland Tumors: A Scoping Review.

Int J Mol Sci

November 2024

Department of Otolaryngology, Academy of Applied Medical and Social Sciences, 82-300 Elblag, Poland.

Salivary gland tumors are rare head and neck tumors constituting up to 6% of all head and neck neoplasms; despite being mostly benign, these tumors present in diverse histological subtypes, making them challenging to diagnose and treat. Our research aims to investigate the link between inflammation and tumorigenesis within the salivary glands based on the literature regarding the etiopathogenesis of benign salivary gland tumors. This scoping review was conducted following the PRISMA extension for scoping reviews and reporting guidelines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!